The US Food and Drug Administration (FDA) is investigating whether semaglutide, the active ingredient of the weight loss drug Wegovy and the diabetes medication Ozempic, might cause hair loss and suicidal thoughts, CNN reports
One of the innovative therapies we offer is semaglutide , a GLP-1 receptor agonist that stands out from traditional weight loss methods due to its unique mechanism of action and impressive clinical results
It's important to personalize the treatment plan based on your individual response and tolerance
Many patients using both medications experience improved blood sugar outcomes within 812 weeks
Understanding which foods to prioritise and which to avoid can meaningfully reduce gastrointestinal side effects, support nutritional adequacy, and help people enrolled in authorised clinical trials get the most from their treatment
Learn how gut health supplements like Flatter Me and Flatter Me Fiber GLP1 Booster can help you poop better and absorb more nutrients